Trial · NCT00070499
Adverse events380
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 380
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hemoglobin | Blood and lymphatic system disorders | Standard Dose Imatinib A | 47 | 72 | 47 |
| other | Hemoglobin | Blood and lymphatic system disorders | High Dose Imatinib | 59 | 72 | 59 |
| other | Hemoglobin | Blood and lymphatic system disorders | Dasatinib | 86 | 122 | 86 |
| other | Hemoglobin | Blood and lymphatic system disorders | Standard Dose Imatinib B | 87 | 123 | 87 |
| other | Vision-blurred vision | Eye disorders | Standard Dose Imatinib A | 5 | 72 | 5 |
| other | Vision-blurred vision | Eye disorders | High Dose Imatinib | 4 | 72 | 4 |
| other | Vision-blurred vision | Eye disorders | Dasatinib | 0 | 122 | 0 |
| other | Vision-blurred vision | Eye disorders | Standard Dose Imatinib B | 7 | 123 | 7 |
| other | Watery eye (epiphora, tearing) | Eye disorders | Standard Dose Imatinib A | 0 | 72 | 0 |
| other | Watery eye (epiphora, tearing) | Eye disorders | High Dose Imatinib | 10 | 72 | 10 |
| other | Watery eye (epiphora, tearing) | Eye disorders | Dasatinib | 0 | 122 | 0 |
| other | Watery eye (epiphora, tearing) | Eye disorders | Standard Dose Imatinib B | 13 | 123 | 13 |
| other | Ascites (non-malignant) | Gastrointestinal disorders | Standard Dose Imatinib A | 0 | 72 | 0 |
| other | Ascites (non-malignant) | Gastrointestinal disorders | High Dose Imatinib | 6 | 72 | 6 |
| other | Ascites (non-malignant) | Gastrointestinal disorders | Dasatinib | 0 | 122 | 0 |
| other | Ascites (non-malignant) | Gastrointestinal disorders | Standard Dose Imatinib B | 0 | 123 | 0 |
| other | Constipation | Gastrointestinal disorders | Standard Dose Imatinib A | 4 | 72 | 4 |
| other | Constipation | Gastrointestinal disorders | High Dose Imatinib | 6 | 72 | 6 |
| other | Constipation | Gastrointestinal disorders | Dasatinib | 9 | 122 | 9 |
| other | Constipation | Gastrointestinal disorders | Standard Dose Imatinib B | 9 | 123 | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00070499/events